Subchronic in vivo treatments of morphine inhibit T-cell proliferation by acting on macrophages

Brain, Behavior, and Immunity

Volumn 10, Issue 4, 1996, Pages 351-363

  Lu, Zheng Wu ^a,b   Dai, Wei Juan ^b   Wang, Gui Lin ^b   Lin, Zhi Bin ^b  

^a CARLETON UNIVERSITY   (Canada)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CONCANAVALIN A; INDOMETACIN; INTERLEUKIN 1; INTERLEUKIN 2; MORPHINE; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG EFFECT; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

EID: 0030485090     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.1996.0031     Document Type: Article

References (39)

1. Adams, D. O. (1980). Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors. J. Immunol. 124, 286-292.
2. Aderem, A. A., Cohen, D. S., Wright, D. S., & Cohn, Z. A. (1986). Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. J. Exp. Med. 164, 165-179.
3. 2-mediated suppression of cellular immunity in colon cancer patients. Surgery 95, 71-77.
4. Becquet, F., Goureau, O., Soubrane, G., Coscas, G., Courtois, Y., & Hicks, D. (1994). Superoxide inhibits proliferation and phagocytic internalization of photoreceptor outer segments by bovine retinal pigment epithelium in vitro. Exp. Cell Res. 212, 374-382.
5. Beller, D. I. (1983). Functional significance of the regulation of macrophage Ia expression. J. Immunol. 14, 138-143.
6. Bryant, H. U., Bernton, E. W., Kenner, J. R., Shakarjian, T. K., & Holaday, J. W. (1988). Suppression of macrophage function and increased lethality to bacterial infection in mice given morphine-pellet implants. FASEB J. 2, A1260.
7. Carr, D. J. J., Gebhardt, B. M., & Paul, D. (1993). Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. J. Pharmacol. Exp. Ther. 264, 1179-1186.
8. Chao, C. C., Sharp, B. M., Pomeroy, C., Filice, G. A., & Peterson, P. K. (1990). Lethality of morphine in mice infected with Toxoplasma gondii. J. Pharmacol. Exp. Ther. 252, 605-609.
9. Collier, H. O. J., Francis, D. L., McDonald, G. W. J., Roy, A. C., & Saeed, S. A. (1975). Prostaglandins, cyclic AMP and the mechanism of opiate dependence. Life Sci. 17, 85-90.
10. Di Francesco, P., Pica, F., Marini, S., Favalli, C., & Garaci, E. (1992). Thymosin alpha one restores murine T-cell-mediated responses inhibited by in vivo cocaine administration. Int. J. Immunopharmacol. 15, 1-9.
11. Dinarello, C. A., & Savage, N. (1989). Interleukin-1 and its receptor. CRC Crit. Rev. Immunol. 9, 1-5.
12. Donahoe, R. M., & Falek, A. (1988). Neuroimmunomodulation by opiates and other drugs of abuse: Relationship to HIV infection and AIDS. In T. Bridge (Ed.), Psychological neuropsychiatric and substance abuse aspects of AIDS, pp. 145-158. Raven Press: New York.
13. Droge, W. (1986). Protein kinase C in T cell regulation. Immunol. Today, 7, 340-343.
14. Eisenstein, T. K., Taub, D. D., Adler, M. W., & Rogers, T. J. (1991). The effect of morphine and DAGO on the proliferative response of murine splenocytes. In H. Friedman (Ed.), Drugs of abuse, immunity, and immunodeficiency, pp. 203-209. Plenum: New York.
15. Elliot, G. R., Van Batenburg, M. J., & Dzolic, M. R. (1987). Morphine dependence modified macrophage eicosanoid release. Agents Actions 23, 32-33.
16. Fecho, K., Maslonek, K. A., Dykstra, L. A., & Lysle, D. T. (1995). Mechanisms whereby macrophage-derived nitric oxide is involved in morphine-induced suppression of splenic lymphocyte proliferation. J. Pharmacol. Exp. Ther. 272, 477-483.
17. Fernandez-Botran, R., Sanders, V. M., Mosmann, T. R., & Vitetta, E. S. (1988). Lymphokine-mediated regulation of the proliferative response of clones of Th1 and Th2 cells. J. Exp. Med. 168, 543-558.
18. Freier, D. O., & Fuchs, B. A. (1993). Morphine-induced alterations in thymocyte subpopulations of B6C3F1 mice. J. Pharmacol. Exp. Ther. 265, 81-88.
19. Fresa, K., Hameed, M., & Cohen, S. (1989). Intracellular mechanisms of lymphoid cell activation. Clin. Immunol. Immunopathol. 50, 8-19.
20. Goodwin, J. S., & Ceuppens, J. (1983). Regulation of the immune response by prostaglandins. J. Clin. Immunol. 3, 295-315.
21. Hemler, M. E., Cook, H. W., & Landis, W. E. (1979). Prostaglandin biosynthesis can be triggered by lipid peroxides. Arch. Biochem. Biophys. 193, 340-345.
22. Ho, W. K. K., Cheung, K. W., Leung, K. N., & Wen, H. L. (1986). Suppression of immunological functions in morphine addicted mice. NIDA Res. Monogr. Ser. 75, 331-334.
23. Josimovits, O., Osawa, H., & Diamantstein, T. (1985). The mode of action of calcium ionophore A23187 on T cell proliferation. I. The ionophore does not replace lymphokines but acts via induction of IL-2 production on IL-2 responsive cells. Immunobiology 170, 164-174.
24. Kurland, J. I., & Bockman, R. (1978). Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J. Exp. Med. 147, 952-957.
25. Los, M., Droge, W., Stricker, K., Baeuerle, P. A., & Schulze-Osthoff, K. (1995). Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur. J. Immunol. 25, 159-165.
26. Lu, Z. W., & Lin, Z. B. (1994). Effects of morphine on phagocytosis, cytotoxicity and cytokines production of macrophages in mice. Bas. Med. Sci. Clin. 14, 351-354.
27. Lu, Z. W. (1995). Psychoneuroimmunological effects of morphine and the immunoprotection of Ganoderma polysaccharides peptide in morphine-dependent mice. Prog. Physiol. Sci. 26, 45-49.
28. Lysle, D. T., Coussons, M. E., Watts, V. J., Bennett, E. H., & Dykstra, L. A. (1993). Morphine-induced alterations of immune status: Dose dependency, compartment specificity, and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 265, 1071-1078.
29. Oppenheim, J. J., Lew, W., Akahoshi, T., Matsushima, K., & Neta, R. (1988). Aspects of cytokine induced modulation of immunity and inflammation with emphasis on interleukin 1. Drug Res. 38, 461-465.
30. Pacifici, R., Di Carlo, S., Bacosi, A., & Zuccaro, P. (1993). Macrophage functions in drugs of abuse-treated mice. Int. J. Immunopharmacol. 15, 711-716.
31. Starec, M., Rouveix, B., Sinet, M., Chau, F., Desforges, B., Pocidalo, J. J., & Lechat, P. (1991). Immune status and survival of opiate-and cocaine-treated mice infected with Friend virus. J. Pharmacol. Exp. Ther. 259, 745-750.
32. 2. Cell. Immunol. 134, 235-240.
33. 2-mediated suppression. Surgery 92, 528-532.
34. Truneh, A., Albert, F., Golstein, P., & Schmitt-Verhulst, A. M. (1985). Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol esters. Nature 313, 318-320.
35. 2 inhibits human T-cell proliferation after crosslinking of the CD3-Ti complex by directly affecting T cells at an early step of the activation process. Cell. Immunol. 104, 24-36.
36. 2-induced inhibition of interleukin 2 production. J. Immunol. 130, 1770-1773.
37. Weber, R. J., & Pert, A. (1989). The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245, 188-190.
38. Whitacre, C. M., & Cathcart, M. K. (1992). Oxygen free radical generation and regulation of proliferative activity of human mononuclear cells responding to different mitogens. Cell. Immunol. 144, 287-295.
39. Zoschke, D. C., & Messner, R. P. (1984). Suppression of human lymphocyte mitogenesis and mediated by phagocyte-released reactive oxygen species: comparative activities in normals and chronic granulomatous disease. Clin. Immunol. Immunopathol. 32, 29-40.